Anthocyanin Preparations for Cardiovascular Disease Prevention
Summary
The European Patent Office published EP3784251A1, a patent application by MedPalett AS covering preparations containing anthocyanins for use in preventing and treating cardiovascular diseases. The application claims compositions under IPC classifications A61K 31/7048 and A61P 9/00 with inventors including Rosario Lizio, Sara Liebaña Viñas, Aldelhak Zoubir, Michael Muma, and Tim Schaeck. The patent designates all EU member states and related countries.
What changed
The EPO published patent application EP3784251A1 for anthocyanin-based preparations targeting cardiovascular disease prevention and treatment. The application claims priority under multiple IPC classifications including A61K 31/7048 (anthocyanin derivatives) and A61P 9/00 (cardiovascular preparations).
Pharmaceutical companies and nutraceutical manufacturers developing anthocyanin-based cardiovascular products should review this patent for potential infringement risks in EU designated states. MedPalett AS now holds published patent rights that may affect freedom-to-operate for competing preparations in this therapeutic area.
What to do next
- Review patent claims for freedom-to-operate analysis
- Monitor for opposition period deadlines in designated states
- Assess potential licensing opportunities with MedPalett AS
Archived snapshot
Apr 10, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
PREPARATIONS CONTAINING ANTHOCYANINS FOR USE IN THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES
Publication EP3784251A1 Kind: A1 Apr 01, 2026
Applicants
MedPalett AS
Inventors
LIZIO, Rosario, LIEBANA VIÑAS, Sara, ZOUBIR, Aldelhak, MUMA, Michael, SCHAECK, Tim
IPC Classifications
A61K 31/7048 20060101AFI20191101BHEP A61K 36/45 20060101ALI20191101BHEP A61K 36/185 20060101ALI20191101BHEP A61P 9/00 20060101ALI20191101BHEP A61P 9/12 20060101ALI20191101BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Get daily alerts for EPO Patent Bulletin - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.